176 related articles for article (PubMed ID: 21469228)
1. The first total synthesis of ganglioside GalNAc-GD1a, a target molecule for autoantibodies in Guillain-Barré syndrome.
Fujikawa K; Nakashima S; Konishi M; Fuse T; Komura N; Ando T; Ando H; Yuki N; Ishida H; Kiso M
Chemistry; 2011 May; 17(20):5641-51. PubMed ID: 21469228
[TBL] [Abstract][Full Text] [Related]
2. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
3. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
5. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
6. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
7. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside complexes as new target antigens in Guillain-Barré syndrome.
Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
Ann Neurol; 2004 Oct; 56(4):567-71. PubMed ID: 15389898
[TBL] [Abstract][Full Text] [Related]
10. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
Mauri L; Casellato R; Ciampa MG; Uekusa Y; Kato K; Kaida K; Motoyama M; Kusunoki S; Sonnino S
Glycobiology; 2012 Mar; 22(3):352-60. PubMed ID: 21921061
[TBL] [Abstract][Full Text] [Related]
11. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
[TBL] [Abstract][Full Text] [Related]
12. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
[TBL] [Abstract][Full Text] [Related]
13. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.
Taguchi K; Ren J; Utsunomiya I; Aoyagi H; Fujita N; Ariga T; Miyatake T; Yoshino H
J Neurol Sci; 2004 Oct; 225(1-2):91-8. PubMed ID: 15465091
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.
Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
Brain; 2000 Jan; 123 ( Pt 1)():116-24. PubMed ID: 10611126
[TBL] [Abstract][Full Text] [Related]
15. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
16. Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia.
Kamakura K; Kaida K; Kusunoki S; Miyamoto N; Masaki T; Nakamura R; Motoyoshi K; Fukuda J
J Peripher Nerv Syst; 2005 Jun; 10(2):190-201. PubMed ID: 15958130
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
Kusunoki S; Kaida K
J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features of neuropathies in a group of patients associated with anti-GalNAc-GD1a antibody].
Tatsumoto M; Odaka M; Koga M; Hirata K; Yuki N
Rinsho Shinkeigaku; 2004 Aug; 44(8):508-12. PubMed ID: 15471085
[TBL] [Abstract][Full Text] [Related]
19. A first total synthesis of a hybrid-type ganglioside associated with amyotrophic lateral sclerosis-like disorder.
Nakashima S; Ando H; Imamura A; Yuki N; Ishida H; Kiso M
Chemistry; 2011 Jan; 17(2):588-97. PubMed ID: 21207577
[TBL] [Abstract][Full Text] [Related]
20. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
